Aigen Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,030
| Closed | -$277K | – | 692 |
|
|
2024
Q2 | $277K | Sell |
17,030
-33,478
| -66% | -$544K | 0.05% | 506 |
|
|
2024
Q1 | $934K | Sell |
50,508
-2,013
| -4% | -$37.2K | 0.2% | 153 |
|
|
2023
Q4 | $1.64M | Buy |
52,521
+37,455
| +249% | +$1.17M | 0.29% | 84 |
|
|
2023
Q3 | $314K | Buy |
+15,066
| New | +$314K | 0.06% | 510 |
|
|
2020
Q4 | – | Sell |
-20,360
| Closed | -$840K | – | 746 |
|
|
2020
Q3 | $840K | Buy |
+20,360
| New | +$840K | 0.11% | 299 |
|